Post-marketing surveillance of Euhypnos (temazepam): a new hypnotic
| Autor: | L K Fowler |
|---|---|
| Rok vydání: | 1980 |
| Předmět: |
Sleep Wake Disorders
Surveillance study medicine.drug_class Postmarketing surveillance 030204 cardiovascular system & hematology Biochemistry MORNING NAUSEA Hypnotic 03 medical and health sciences Temazepam 0302 clinical medicine medicine Humans Adverse effect Benzodiazepine business.industry Biochemistry (medical) Headache Cell Biology General Medicine Dreams Anti-Anxiety Agents 030220 oncology & carcinogenesis Anesthesia Sleep Stages business Digestive System medicine.drug |
| Zdroj: | The Journal of international medical research. 8(4) |
| ISSN: | 0300-0605 |
| Popis: | A post-marketing surveillance study of Euhypnos (temazepam), a new short-acting benzodiazepine hypnotic. A total of 12,350 patients requiring a sleep inducer were treated for up to 3 months with doses of 10–30 mg at night. After 2 weeks 80% of First Reports (FRs) rated Euhypnos effective and at 3 months this had risen to 92% of 3062 Second Reports (SRs). Hangover was reported in 7% of FRs and 2% of SRs but in general the drug was well tolerated with adverse reactions consisting mainly of morning nausea, headache, drowsiness and vivid dreaming. Eighty-seven per cent of FRs and 93% of SRs were ‘Clean’ reporting no hangover, adverse reaction or event of any kind. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|